Pfizer to make Gilead’s COVID-19 treatment remdesivir

This post was originally published on this site(Reuters) – Pfizer Inc (PFE.N) said on Friday it signed a multi-year agreement to make Gilead Sciences Inc’s (GILD.O) antiviral drug

Read More

Merck to move COVID-19 treatment into large trials, sees sales recovering this year

This post was originally published on this site(Reuters) – Merck & Co (MRK.N) on Friday said it plans to advance an antiviral treatment for COVID-19 into large studies in the coming

Read More

Merck quarterly profit buoyed by Keytruda demand as COVID-19 hammers sales

This post was originally published on this site(Reuters) – Merck & Co Inc (MRK.N) on Friday posted a higher-than-expected quarterly profit and raised its full-year earnings forecast on

Read More

Eli Lilly starts mid-stage study of COVID-19 treatment

This post was originally published on this site(Reuters) – Eli Lilly and Co (LLY.N) said on Thursday it had started mid-stage testing of one of its experimental treatments for COVID-19, as

Read More

Pfizer says it will charge other developed countries on par with US for vaccine deals

This post was originally published on this site(Reuters) – Pfizer Inc (PFE.N) on Tuesday said other developed countries would not get a lower price for its coronavirus vaccine than what it

Read More

Moderna, Merck say they will not limit price of coronavirus vaccines to company cost

This post was originally published on this site(Reuters) – Moderna Inc and Merck & Co on Tuesday told a U.S. Congressional panel that they expect to profit from their coronavirus

Read More

J&J says large study of coronavirus vaccine could begin in September

This post was originally published on this site(Reuters) – Johnson & Johnson (JNJ.N) said on Thursday it is aiming to begin in September a late-stage study of its experimental vaccine

Read More

J&J raises forecast after quarterly profit beats estimates

This post was originally published on this site(Reuters) – Johnson & Johnson (JNJ.N) raised its full-year profit forecast and beat analysts’ estimates for quarterly earnings on

Read More

Pfizer, BioNTech’s coronavirus vaccine candidates get FDA’s ‘fast track’ status

This post was originally published on this site(Reuters) – Two experimental coronavirus vaccines jointly developed by German biotech firm BioNTech (BNTX.O) and U.S. pharmaceutical giant

Read More

New $1 billion fund aims to steer antibiotic companies in tough market

This post was originally published on this site(Reuters) – Several large drugmakers including Merck & Co Inc (MRK.N) and Pfizer Inc (PFE.N) on Thursday unveiled a $1 billion fund to

Read More